The biological significance of tumor grade, age, enhancement, and extent of resection in IDH-mutant gliomas: How should they inform treatment decisions in the era of IDH inhibitors? - van den Bent MJ; French PJ; Brat D; Tonn JC; Touat M; Ellingson BM; Young RJ; Pallud J; von Deimling A; Sahm F; Figarella Branger D; Huang RY; et al. (Neuro-oncology, 2024)